Scholarlink

Background and aims <p>Pancreatic duct leaks and fistulas are challenging complications of pancreatitis and pancreatic surgery. Although endoscopic retrograde pancreatic duct drainage (ERPD) is widely used, optimal drainage strategies remain incompletely defined. This study aimed to evaluate outcomes and identify predictors of clinical success of ERPD in patients with pancreatic leaks and fistulas.</p> Methods <p>We conducted a multicenter retrospective study of consecutive patients with pancreatic duct leaks or fistulas refractory to conservative therapy who underwent ERPD at four tertiary centers between July 2007 and August 2023. Fistulas were classified using an endoscopy-oriented system. Drainage strategies were categorized as type A (stent placed across the leak), type B (stent placed adjacent to the leak), or type C (stent placed into the collection cavity). The primary outcome was clinical success within 3 months. Independent predictors of clinical success were assessed using multivariable logistic regression.</p> Results <p>A total of 106 patients were included. Technical success was achieved in 98.2% of procedures, and overall clinical success was 79.2%. Clinical success rates were similar between pancreatitis-related leaks and postoperative or traumatic leaks (78.9% vs. 80.0%, <i>P</i> = 0.893). Leak-bridging drainage (type A) was associated with a significantly higher clinical success rate than non–leak-bridging drainage (94.4% vs. 71.4%). Type IIC fistulas had the lowest success rate (36.4%). On multivariable analysis, leak-bridging drainage independently predicted clinical success (OR 6.5, 95% CI 1.3–31.2; <i>P</i> = 0.020), whereas type IIC fistulas were associated with reduced odds of success (OR 0.114, 95% CI 0.027–0.476; <i>P</i> = 0.003). When leak bridging was not feasible, type B drainage achieved higher success than type C drainage (83.3% vs. 53.6%, <i>P</i> = 0.007).</p> Conclusions <p>ERPD is a safe and effective treatment for pancreatic duct leaks and fistulas. Leak-bridging drainage is strongly associated with clinical success and should be prioritized whenever feasible. When bridging cannot be achieved, stent placement adjacent to the leak appears more effective than intracavitary drainage. Type IIC fistulas remain challenging and may require alternative or adjunctive interventions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Outcomes and predictors of success of endoscopic retrograde pancreatic drainage for pancreatic leaks and fistulas: a multicenter retrospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月23日

查看全文
  • Dexin Chen,
  • Ziyi He,
  • Yanling Peng,
  • Changqin Li,
  • Zhidong Xing,
  • Yuming Han,
  • Guanjun Zhang,
  • Shengxin Chen,
  • Yawen Liang,
  • Lichao Zhang,
  • Hui Ding,
  • Zhenjuan Li,
  • Haowen Dai,
  • Yaqi Zhai,
  • Mingyang Li

摘要

Background and aims

Pancreatic duct leaks and fistulas are challenging complications of pancreatitis and pancreatic surgery. Although endoscopic retrograde pancreatic duct drainage (ERPD) is widely used, optimal drainage strategies remain incompletely defined. This study aimed to evaluate outcomes and identify predictors of clinical success of ERPD in patients with pancreatic leaks and fistulas.

Methods

We conducted a multicenter retrospective study of consecutive patients with pancreatic duct leaks or fistulas refractory to conservative therapy who underwent ERPD at four tertiary centers between July 2007 and August 2023. Fistulas were classified using an endoscopy-oriented system. Drainage strategies were categorized as type A (stent placed across the leak), type B (stent placed adjacent to the leak), or type C (stent placed into the collection cavity). The primary outcome was clinical success within 3 months. Independent predictors of clinical success were assessed using multivariable logistic regression.

Results

A total of 106 patients were included. Technical success was achieved in 98.2% of procedures, and overall clinical success was 79.2%. Clinical success rates were similar between pancreatitis-related leaks and postoperative or traumatic leaks (78.9% vs. 80.0%, P = 0.893). Leak-bridging drainage (type A) was associated with a significantly higher clinical success rate than non–leak-bridging drainage (94.4% vs. 71.4%). Type IIC fistulas had the lowest success rate (36.4%). On multivariable analysis, leak-bridging drainage independently predicted clinical success (OR 6.5, 95% CI 1.3–31.2; P = 0.020), whereas type IIC fistulas were associated with reduced odds of success (OR 0.114, 95% CI 0.027–0.476; P = 0.003). When leak bridging was not feasible, type B drainage achieved higher success than type C drainage (83.3% vs. 53.6%, P = 0.007).

Conclusions

ERPD is a safe and effective treatment for pancreatic duct leaks and fistulas. Leak-bridging drainage is strongly associated with clinical success and should be prioritized whenever feasible. When bridging cannot be achieved, stent placement adjacent to the leak appears more effective than intracavitary drainage. Type IIC fistulas remain challenging and may require alternative or adjunctive interventions.